Article
Intratumoral viable biological agent as a Multi-Mechanism Therapeutic Strategy for Pancreatic Adenocarcinoma
2026-02-04
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Pancreatic ductal adenocarcinoma (PDAC) exhibits five-year survival rates below 10% with profound therapeutic resistance mediated by stromal barriers and immunosuppression [1,2]. Recent evidence suggests intratumoral mycobiome alterations may influence disease progression [17,18]. <bold>Methods:</bold> We performed comprehensive network pharmacology analysi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c1a2b897-c2ce-58b4-a65c-15deb53b6bce
- DOI
- 10.21203/rs.3.rs-8768147/v1
